Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss
NCT07506512
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Early Pregnancy Loss
Interventions
DRUG:
200mg mifepristone and 800mg misoprostol
Sponsor
University of Pennsylvania